Clinical study of meta-injection precision optimization of infectious shock cycle functio

Not Applicable

• Conditions: Infectious shock

• Registration Number: ITMCTR2200005614
• Lead Sponsor: orthern Jiangsu People's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.the age is between 18 and 80 years old,male or female.2.Compliance with infectious shock diagnostic criteria, on the basis of sepsis, there is a continuous low blood pressure, and vascular active drugs are still needed after full capacity recovery to maintain average arterial pressure (MAP) = 65mmHg, and blood lactate concentration>2mmol/L.3.Check at the ICU within 24 hours.4. No vascular active drugs are used when admission.5. voluntarily signed an informed consent.

Exclusion Criteria

1. acute cerebrovascular disease, malignant tumor.2.Pregnancy or lactating women.3.Drug allergies during medication.4.The efficacy or safety judgment is not judged by specified medication.5.Heartborne shock, blood loss shock, obstructive shock, caused by other reasons.6.Other clinical trials have participated in other clinical trials over the past three months

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vascular active drug use time;

Secondary Outcome Measures

Name	Time	Method
28 days sorrow rate;Liver and kidney function;Hemodynamic index;Liquid balance before a week;Liver and kidney function;Lac;Coagulation function;ICU hospital stay;Inflammatory factor level;Adverse reactions;Mechanical ventilation time;